Nicotinamide Mononucleotide (NMN): Difference between revisions

no edit summary
No edit summary
No edit summary
Line 165: Line 165:
* improvement in muscle insulin sensitivity is clinically relevant and is similar to the improvement observed after ~10% weight loss
* improvement in muscle insulin sensitivity is clinically relevant and is similar to the improvement observed after ~10% weight loss
|-
|-
|Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study <ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265078/</ref>
|Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study {{#pmid:34238308}}
|[[RCT]], 6 weeks
|[[RCT]], 6 weeks
* placebo (n=12)
* placebo (n=12)